Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine Kinase
- 1 August 2000
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 67 (2), 295-301
- https://doi.org/10.1086/303019
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Gene for Lymphedema-Distichiasis Maps to 16q24.3American Journal of Human Genetics, 1999
- A Gene for Inherited Cutaneous Venous Anomalies (“Glomangiomas”) Localizes to Chromosome 1p21-22American Journal of Human Genetics, 1999
- Mapping of Primary Congenital Lymphedema to the 5q35.3 RegionAmerican Journal of Human Genetics, 1999
- Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation responseOncogene, 1999
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- Assignment of a locus for dominantly inherited venous malformations to chromosome 9pHuman Molecular Genetics, 1994
- Novel Mutations of the KIT (Mast/Stem Cell Growth Factor Receptor) Proto-Oncogene in Human PiebaldismJournal of Investigative Dermatology, 1993
- Editorial comment on the paper by Crowe and Dickerman: On congenital lymphedemaAmerican Journal of Medical Genetics, 1986
- Strategies for multilocus linkage analysis in humans.Proceedings of the National Academy of Sciences, 1984
- Congenital Hereditary LymphoedemaJournal of Medical Genetics, 1965